Skip to content

Beneficient BENF Other assets

Other assets at other companies

Boston Omaha logo
Boston OmahaBOC
$13.9M-6.7%
Blackbaud logo
BlackbaudBLKB
$7.61M+68.2%
Xerox Holdings Corporation logo
Xerox Holdings CorporationXRX
$30M+30.4%
LAD
Lithia MotorsLAD
$421.3M-2.1%
BioSig Technologies, Inc. logo
BioSig Technologies, Inc.STEX
$1M
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$11.54M+51.1%

Segments

By segment

See full
Ben Custody$22.23M+4.4%
Ben Liquidity$1.06M-7.4%

Other financials

Income statement

See full
Revenue$18.7M+322%
Operating income$3.9M+141%
Net income$19.9M+331%
EPS (diluted)-$0.49+26.5%

Balance sheet

See full
Cash & equivalents$7.9M+87.3%
Total debt$100.3M-16.6%
Total equity-$128.6M-1,002%
Total assets$337.9M-15.5%

Cash flow

See full
Operating cash flow-$9.4M+6.3%
CapEx$96.0K-85.5%
Free cash flow-$9.4M+6.7%

Valuation

See full
Market cap$52.86M+2,018%
Enterprise value$145.33M+40.6%

Profitability

See full
Operating margin548.5%-323pp
Net margin517.9%-235pp
FCF margin156.8%-40.4pp

Returns & leverage

See full
Return on equity-1,647.1%-2,080pp
Debt / equity8.4×-23.8×

Where this comes from

Reported directly by Beneficient in its filing.

Tagged under the XBRL concept ben:CashAndCashEquivalentsRestrictedCashAndOtherAssets.

The official record: Beneficient’s 10-Q, filed February 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beneficient's other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Beneficient's other assets?
Beneficient (BENF) reported other assets of $119.07M in Q4 2025.
How has Beneficient's other assets changed year-over-year?
Beneficient's other assets increased by 125.9% year-over-year, from $52.72M to $119.07M.
What is the long-term trend for Beneficient's other assets?
Over 3 years (2022 to 2025), Beneficient's other assets has grown at a -19.3% compound annual growth rate (CAGR), from $95.99M to $50.49M.
What does other assets mean?
Includes cash and liquid assets that are not available for immediate general corporate use due to contractual, regulatory, or legal restrictions. This metric is vital for assessing the company's true liquidity position and its ability to meet short-term obligations. It distinguishes between readily accessible working capital and funds earmarked for specific commitments or collateral requirements.